Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Current Assets (2016 - 2025)

Historic Current Assets for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to $782.1 million.

  • Ocular Therapeutix's Current Assets rose 7735.87% to $782.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $782.1 million, marking a year-over-year increase of 7735.87%. This contributed to the annual value of $782.1 million for FY2025, which is 7735.87% up from last year.
  • According to the latest figures from Q4 2025, Ocular Therapeutix's Current Assets is $782.1 million, which was up 7735.87% from $387.0 million recorded in Q3 2025.
  • In the past 5 years, Ocular Therapeutix's Current Assets ranged from a high of $782.1 million in Q4 2025 and a low of $100.7 million during Q2 2023
  • Its 5-year average for Current Assets is $297.7 million, with a median of $222.3 million in 2021.
  • Its Current Assets has fluctuated over the past 5 years, first tumbled by 3864.26% in 2023, then surged by 39506.02% in 2024.
  • Quarter analysis of 5 years shows Ocular Therapeutix's Current Assets stood at $191.3 million in 2021, then crashed by 32.24% to $129.6 million in 2022, then skyrocketed by 79.16% to $232.2 million in 2023, then soared by 89.89% to $441.0 million in 2024, then soared by 77.36% to $782.1 million in 2025.
  • Its Current Assets stands at $782.1 million for Q4 2025, versus $387.0 million for Q3 2025 and $433.4 million for Q2 2025.